Specialty code 1835P0018X · Modesto, CA
NPI
1255818688
Since 2018
Specialty
Specialty code 1835P0018X
Code 1835P0018X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3800 Dale Rd
Modesto, CA, 95356
Phone (209) 662-7517
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$416K
2,119 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Siona M Emerson prescribed most often to Medicare patients was Ozempic (Semaglutide), with 218 prescriptions and refills. In total Siona M Emerson wrote 2,119 Medicare prescriptions that cost $416K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 218 | 222 | 58 | $161K |
| Atorvastatin Calcium Generic | 180 | 597 | 78 | $2,257 |
| Metformin Hcl Er Metformin Hcl | 175 | 582 | 81 | $1,884 |
| Insulin Glargine-Yfgn Generic | 130 | 334 | 52 | $17K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 116 | 341 | 46 | $3,115 |
| Metformin Hcl Generic | 107 | 345 | 58 | $1,240 |
| Glipizide Er Glipizide | 93 | 309 | 40 | $2,560 |
| Jardiance Empagliflozin | 75 | 250 | 44 | $42K |
| Rosuvastatin Calcium Generic | 71 | 237 | 30 | $825 |
| Victoza 2-Pak Liraglutide | 66 | 71 | 16 | $45K |
| Humulin N Insulin Nph Human Isophane | 61 | 176 | 27 | $12K |
| Glipizide Generic | 61 | 203 | 39 | $730 |
| Lisinopril Generic | 59 | 194 | 27 | $692 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 56 | 157 | 25 | $13K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 54 | 160 | 21 | $20K |
Brand drugs: 843 claims; generic drugs: 1,032 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Siona M Emerson were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.